Cargando…

How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?

SIMPLE SUMMARY: Although immune checkpoint inhibitors (ICIs) have achieved great progression in cancer treatment, the efficacy of ICI monotherapy is still limited. Meanwhile, the negative efficacy of thermal ablation for liver metastases is the high rate of local tumor progression. Since thermal abl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minami, Yasunori, Takaki, Haruyuki, Yamakado, Koichiro, Kudo, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103121/ https://www.ncbi.nlm.nih.gov/pubmed/35565338 http://dx.doi.org/10.3390/cancers14092206

Ejemplares similares

Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2013)

Radiofrequency Ablation Combined with Hepatic Artery Embolization Using a Tris-acryl Gelatin Microsphere for Colorectal Liver Metastases-Initial Experience
por: Moriyama, Taiki, et al.
Publicado: (2023)

Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
por: Minami, Yasunori, et al.
Publicado: (2023)

Long-term survival following radiofrequency ablation of lung metastases in an elderly patient with calcaneal osteosarcoma: A case report and review of the literature
por: Futani, Hiroyuki, et al.
Publicado: (2021)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Adrenal pheochromocytoma treated by combination of adrenal arterial embolization and radiofrequency ablation
por: Kako, Yasukazu, et al.
Publicado: (2021)

Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging
por: Minami, Yasunori, et al.
Publicado: (2021)

Liver regeneration after portal vein embolization: comparison between absolute ethanol and N-butyl-cyanoacrylate in an in vivo rat model
por: Maruyama, Mitsunari, et al.
Publicado: (2023)

(11)C-Choline-Avid but (18)F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
por: Kitajima, Kazuhiro, et al.
Publicado: (2016)

Clinical Experience of Percutaneous Radiofrequency Ablation Using an arfa RF ABLATION SYSTEM(Ⓡ) in Various Organs
por: Kinota, Naoya, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint blockade for brain metastases
por: Harary, Maya, et al.
Publicado: (2019)

Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Immune checkpoint inhibitor in liver cancer—unique regional differences
por: Obi, Shuntaro, et al.
Publicado: (2020)

Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration
por: Minami, Yasunori, et al.
Publicado: (2021)

The gut microbiota and immune checkpoint inhibitors
por: Humphries, Audrey, et al.
Publicado: (2018)

Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases
por: Vasiniotis Kamarinos, Nikiforos, et al.
Publicado: (2022)

Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings
por: De Muzio, Federica, et al.
Publicado: (2022)

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
por: Nishida, Naoshi, et al.
Publicado: (2020)

Successful radiofrequency ablation of liver metastases from prostate cancer
por: Hino, Daichi, et al.
Publicado: (2022)

Immune checkpoint inhibitor-related acral vasculitis
por: Comont, Thibault, et al.
Publicado: (2018)

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
por: Adashek, Jacob J., et al.
Publicado: (2019)

P-value, compatibility, and S-value
por: Mansournia, Mohammad Ali, et al.
Publicado: (2022)

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
por: Chatterjee, Samit, et al.
Publicado: (2017)

Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases
por: Laimer, Gregor, et al.
Publicado: (2021)

Resection and thermal hepatic ablation of pancreatic neuroendocrine tumor liver metastases for prolonged survival
por: Ke, Xindi, et al.
Publicado: (2022)

Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation
por: Odet, Julien, et al.
Publicado: (2023)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
por: Jardim, Denis L., et al.
Publicado: (2018)

Antibiotic therapy and outcome from immune-checkpoint inhibitors
por: Pinato, David J., et al.
Publicado: (2019)

COVID-19 and immune checkpoint inhibitors: initial considerations
por: Sullivan, Ryan J, et al.
Publicado: (2020)

Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013
por: Gillams, Alice, et al.
Publicado: (2015)

Role of Thermal Ablation in Colorectal Cancer Lung Metastases
por: Delpla, Alexandre, et al.
Publicado: (2021)

Correction to: Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases
por: Laimer, Gregor, et al.
Publicado: (2021)

Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence
por: Minami, Yasunori, et al.
Publicado: (2022)

Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?
por: Dillman, Robert O.
Publicado: (2016)

Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity
por: Lee, Karla A, et al.
Publicado: (2020)

Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
por: Akhuba, Liia, et al.
Publicado: (2023)

Is translational research compatible with preclinical publication strategies?
por: Linder, Stig, et al.
Publicado: (2006)

Immune checkpoint inhibitors: here to stay
por: Carvalho, Filomena Marino, et al.
Publicado: (2023)

Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?
por: DANIŞAN, Gürkan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5d8pq14vitk74roba9b54qf2jn